Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Atorvastatin inhibits the inflammatory response caused by anti-M(3) peptide IgG in patients with primary Sjögren's syndrome.

Reina S, Passafaro D, Sterin-Borda L, Borda E.

Inflammopharmacology. 2012 Oct;20(5):267-75. doi: 10.1007/s10787-012-0132-x. Epub 2012 Mar 23.

PMID:
22441579
2.

Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sjögren's syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands.

Reina S, Sterin-Borda L, Passafaro D, Borda E.

Arch Oral Biol. 2011 May;56(5):413-20. doi: 10.1016/j.archoralbio.2010.08.017. Epub 2011 Mar 3.

PMID:
21371688
3.

Action of anti-M₃muscarinic acetylcholine receptor IgG of primary Sjögren's syndrome on the enzymatic antioxidant system in rat submandibular gland.

Reina S, Rodríguez M, Stranieri G, Borda E.

J Oral Pathol Med. 2015 Nov;44(10):876-83. doi: 10.1111/jop.12313. Epub 2015 Feb 27.

PMID:
25726719
4.

Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2 and cyclic AMP.

Passafaro D, Reina S, Sterin-Borda L, Borda E.

Eur J Oral Sci. 2010 Apr;118(2):131-8. doi: 10.1111/j.1600-0722.2010.00716.x.

PMID:
20487001
5.

Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.

Dawson LJ, Allison HE, Stanbury J, Fitzgerald D, Smith PM.

Rheumatology (Oxford). 2004 Dec;43(12):1488-95. Epub 2004 Sep 7.

PMID:
15353609
6.
7.

Anti-M(3) peptide IgG from Sjögren's syndrome triggers apoptosis in A253 cells.

Reina S, Sterin-Borda L, Borda E.

Cell Immunol. 2012 Jan-Feb;275(1-2):33-41. doi: 10.1016/j.cellimm.2012.03.006. Epub 2012 Apr 3.

PMID:
22513175
8.
9.

Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.

Kim N, Shin Y, Choi S, Namkoong E, Kim M, Lee J, Song Y, Park K.

J Dent Res. 2015 May;94(5):722-8. doi: 10.1177/0022034515577813. Epub 2015 Mar 17.

PMID:
25784251
10.

Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.

Koo NY, Li J, Hwang SM, Choi SY, Lee SJ, Oh SB, Kim JS, Lee EB, Song YW, Park K.

Rheumatology (Oxford). 2008 Jun;47(6):828-33. doi: 10.1093/rheumatology/ken064. Epub 2008 Apr 9.

PMID:
18400835
11.

Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.

Li J, Ha YM, Kü NY, Choi SY, Lee SJ, Oh SB, Kim JS, Lee JH, Lee EB, Song YW, Park K.

Lab Invest. 2004 Nov;84(11):1430-8.

12.

Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.

Jin M, Hwang SM, Davies AJ, Shin Y, Bae JS, Lee JH, Lee EB, Song YW, Park K.

Biochim Biophys Acta. 2012 Feb;1822(2):161-7. doi: 10.1016/j.bbadis.2011.11.012. Epub 2011 Nov 21.

13.
14.

New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.

Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.

Clin Exp Immunol. 2010 Oct;162(1):53-61. doi: 10.1111/j.1365-2249.2010.04188.x. Epub 2010 Aug 20.

15.

Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.

Bacman S, Berra A, Sterin-Borda L, Borda E.

Invest Ophthalmol Vis Sci. 2001 Feb;42(2):321-7.

PMID:
11157861
16.

[Analysis of epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome].

Tsuboi H, Matsuo N, Iizuka M, Nakamura Y, Matsumoto I, Sumida T.

Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(4):222-8. Review. Japanese.

PMID:
20818151
17.

Atorvastatin inhibits inflammatory hypernociception.

Santodomingo-Garzón T, Cunha TM, Verri WA Jr, Valério DA, Parada CA, Poole S, Ferreira SH, Cunha FQ.

Br J Pharmacol. 2006 Sep;149(1):14-22. Epub 2006 Jul 24.

18.

Cholinoreceptor autoantibodies in Sjögren syndrome.

Reina S, Orman B, Anaya JM, Sterin-Borda L, Borda E.

J Dent Res. 2007 Sep;86(9):832-6.

PMID:
17720850
19.

Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis.

Orman B, Sterin-Borda L, De Couto Pita A, Reina S, Borda E.

Int Immunopharmacol. 2007 Dec 5;7(12):1535-43. Epub 2007 Aug 16.

PMID:
17920530
20.

Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.

He J, Zhao J, Li Z.

Arthritis Res Ther. 2008;10(2):R44. doi: 10.1186/ar2403. Epub 2008 Apr 18.

Supplemental Content

Support Center